Shah et al evaluated outcomes for the recipient twin in the twin-twin transfusion syndrome. The recipient twin may develop a cardiomyopathy which may affect the clinical course. The authors are from the University of Cincinnati and Cincinnati Children's Hospital.
Patient selection: recipient twin in the twin-twin transfusion syndrome
Parameter:
(1) cardiovascular profile score (CVPS) of Huhta, which is a measure of congestive heart failure
CVPS
30-Day Survival
< 9
31%
9
50%
10 (maximum)
74%
Atrioventricular valve (mitral and/or tricuspid) regurgitation is associated with negative outcomes.
One proposal is to upstage Quintero stage I or II for the recipient twin if there is evidence of cardiac findings on echocardiography.
To read more or access our algorithms and calculators, please log in or register.
